Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

KRM Ayurveda Ltd (KRMAYURVED) Share Price & Fundamentals

Company Overview

Founded Year

2019

Listed Year

2024

Headquarter

-

MD/CEO

-

Website

-

Company Facts

What we do

KRM Ayurveda Ltd operates hospitals and clinics delivering authentic Ayurvedic care integrating traditional wisdom with modern practices for chronic and lifestyle diseases.

Founded in

2,019

Market share

Emerging player with a growing presence across India and international telemedicine markets in Ayurvedic healthcare.

Problem solved

Addresses chronic diseases like kidney disorders, diabetes, and arthritis through holistic and personalized Ayurvedic treatments.

Top clients or who we serve

Serves patients seeking Ayurvedic care for chronic and lifestyle health issues; B2C focus with expanding tele-consultancy globally.

Key management

-

Our journey and innovations

Started as a kidney hospital in 2019, expanded scope to multiple disorders, and integrated telemedicine for global reach.

Where we operate

Operates 6 hospitals and 5 clinics across Indian cities; telemedicine services extend presence internationally.

Top products or what we offer

In-patient and outpatient care, specialized clinics, wellness packages, Ayurvedic medicines, diet and lifestyle counseling.

Top brands

-

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue mainly from healthcare services and medicinal sales, combining recurring patient care and cyclical wellness packages.

Our industry position

New entrant expanding healthcare offerings in the Ayurvedic segment with telemedicine capabilities enhancing reach.

Financial highlights

Fiscal 2023 revenue Rs 76.55 crore; net profit Rs 12.1 crore, demonstrating profitable growth post incorporation.

Geographical revenue split

-

Order book

-

Whats driving growth

Diversification of treatment areas, integration of telemedicine, and growing demand for holistic chronic disease management.

Our future plans

Planning an IPO to raise funds for network expansion and scaling specialized Ayurvedic services.

Our green promise

-

Our people and values

-

Key challenges ahead

Scaling operations while maintaining care quality; increasing brand awareness in competitive healthcare industry.

Interesting facts

-

Risks and strategy

-

Market Footprint

Top Clients

Top Clients

Serves patients seeking Ayurvedic care for chronic and lifestyle health issues; B2C focus with expanding tele-consultancy globally.

Top Products

Top Products

In-patient and outpatient care, specialized clinics, wellness packages, Ayurvedic medicines, diet and lifestyle counseling.

Price Movement & Share Holding

Today's High/Low

235.25242

52 Week High/Low

156.15343.95
Past Returns

1 week

0.15%

1 month

-20.4%

3 month

-5.72%

1 year

31.85%

3 year

31.85%

5 year

31.85%

Share Holding

Promoters

69.3%

FII

1.54%

DII

2.66%

Retail

19.23%

Others

7.26%

Company Overview

Founded Year

2019

Listed Year

2024

Headquarter

-

MD/CEO

-

Website

-

Price Movement & Share Holding

Today's High/Low

235.25242

52 Week High/Low

156.15343.95

Past Returns

1 week

0.15%

1 month

-20.4%

3 month

-5.72%

1 year

31.85%

3 year

31.85%

5 year

31.85%

Share Holding

Promoters

69.3%

FII

1.54%

DII

2.66%

Retail

19.23%

Others

7.26%

Company Facts

What we do

KRM Ayurveda Ltd operates hospitals and clinics delivering authentic Ayurvedic care integrating traditional wisdom with modern practices for chronic and lifestyle diseases.

Founded in

2019

Market share

Emerging player with a growing presence across India and international telemedicine markets in Ayurvedic healthcare.

Problem solved

Addresses chronic diseases like kidney disorders, diabetes, and arthritis through holistic and personalized Ayurvedic treatments.

Top clients or who we serve

Serves patients seeking Ayurvedic care for chronic and lifestyle health issues; B2C focus with expanding tele-consultancy globally.

Our journey and innovations

Started as a kidney hospital in 2019, expanded scope to multiple disorders, and integrated telemedicine for global reach.

Where we operate

Operates 6 hospitals and 5 clinics across Indian cities; telemedicine services extend presence internationally.

Top products or what we offer

In-patient and outpatient care, specialized clinics, wellness packages, Ayurvedic medicines, diet and lifestyle counseling.

Recurring vs cyclical contribution

Revenue mainly from healthcare services and medicinal sales, combining recurring patient care and cyclical wellness packages.

Our industry position

New entrant expanding healthcare offerings in the Ayurvedic segment with telemedicine capabilities enhancing reach.

Financial highlights

Fiscal 2023 revenue Rs 76.55 crore; net profit Rs 12.1 crore, demonstrating profitable growth post incorporation.

Whats driving growth

Diversification of treatment areas, integration of telemedicine, and growing demand for holistic chronic disease management.

Our future plans

Planning an IPO to raise funds for network expansion and scaling specialized Ayurvedic services.

Key challenges ahead

Scaling operations while maintaining care quality; increasing brand awareness in competitive healthcare industry.

Market Footprint

Top Clients

Top Clients

Serves patients seeking Ayurvedic care for chronic and lifestyle health issues; B2C focus with expanding tele-consultancy globally.

Top Products

Top Products

In-patient and outpatient care, specialized clinics, wellness packages, Ayurvedic medicines, diet and lifestyle counseling.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions